Literature DB >> 1158386

Modifications in the handling in vitro of 125I-labelled keyhole limpet haemocyanin by peritoneal macrophages from mice pretreated with the adjuvant Corynebacterium parvum.

E Wiener, A Bandieri.   

Abstract

Peritoneal macrophages were isolated from C. parvum-pretreated (CP) and normal CBAT6T6 mice and their in vitro handling of 125I-labelled Keyhole limpet haemocyanin (125I-labelled KLH) studied in relation to the humoral anti-KLH responses induced in corresponding animals. CP pretreatment exerted an adjuvant effect on the production of anti-KLH antibodies, both IgM and IgG, which was also demonstrable with a normally subimmunogenic dose of antigen. There was a clear difference between the handling of 125I-labelled KLH by CP and normal macrophages. The initial uptake of the antigen by CP macrophages was slower than that by normal ones. Moreover, 125I-labelled KLH was degraded to a lesser extent within CP macrophages, although the rates of antigen digestion were similar in both kinds of cells. The lower extent of 125I-labelled KLH degradation within the CP macrophages was due to a larger amount of antigen being retained on the cell membrane, where it escapes digestion. The findings suggest that intensified presentation to lymphocytes of antigen on the macrophage surface could be a causal factor in the adjuvant action of CP.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1158386      PMCID: PMC1445948     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  6 in total

1.  [STIMULATION OF THE PHAGOCYTIC ACTIVITY OF THE RETICULOENDOTHELIAL SYSTEM BY CORYNEBACTERIUM PARVUM].

Authors:  B N HALPERN; A R PREVOT; G BIOZZI; C STIFFEL; D MOUTON; J C MORARD; Y BOUTHILLIER; C DECREUSEFOND
Journal:  J Reticuloendothel Soc       Date:  1964-01

2.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

3.  Biological effects of Corynebacterium parvum. IV. Adjuvant and inhibitory activities on B lymphocytes.

Authors:  J G Howard; G H Christie; M T Scott
Journal:  Cell Immunol       Date:  1973-05       Impact factor: 4.868

4.  Lympho-reticular stimulatory properties of Corynebacterium parvum and related bacteria.

Authors:  C Adlam; M T Scott
Journal:  J Med Microbiol       Date:  1973-08       Impact factor: 2.472

5.  [Study of the phenomenon of immuno-cyto-adherence during immunization].

Authors:  G Biozzi; C Stiffel; D Mouton; M Liacopoulosbriot; C Decreusefond; Y Bouthillier
Journal:  Ann Inst Pasteur (Paris)       Date:  1966-03

6.  The uptake and digestion of iodinated human serum albumin by macrophages in vitro.

Authors:  B A Ehrenreich; Z A Cohn
Journal:  J Exp Med       Date:  1967-11-01       Impact factor: 14.307

  6 in total
  6 in total

1.  The characteristics of binding of Corynebacterium parvum to glass-adherent mouse peritoneal exudate cells.

Authors:  H M Ogmundsdóttir; D M Weir
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

2.  The role of macrophages in the adjuvant effect on antibody production of Corynebacterium parvum.

Authors:  S R Watson; V S Sljivić
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

3.  Enhancement of the antibody response in vitro by adherent cells from mice infected with Mycobacterium lepraemurium.

Authors:  S R Watson; I N Brown; V S Sljivić
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

Review 4.  Immunocompetent cells in resistance to bacterial infections.

Authors:  P A Campbell
Journal:  Bacteriol Rev       Date:  1976-06

5.  Dissociation of bactericidal activity from other functions of activated macrophages in exudates induced by thioglycolate medium.

Authors:  G L Spitalny
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

6.  The adjuvant effect of Corynebacterium parvum: T-cell dependence of macrophage activation.

Authors:  V S Sljivić; S R Watson
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.